Search Results 661-670 of 18187 for Hepatitis b

  1. Antibody Treatment for Advanced Celiac Disease - Mayo Clinic

    Patients who have chronic hepatitis B or chronic hepatitis C; Pregnant or breastfeeding women. Women who not using an acceptable method of contraception ...

  2. Fecal Microbiota Transplant / Living Donor Kidney Program / Hepatitis C: Mayo Clinic Radio

    Stacey Rizza outlines the risk of being infected with hepatitis C, especially for people born between 1945 and 1965. Here's the Mayo Clinic Radio podcast ...

  3. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    Participation eligibility · Presence of hepatitis B surface antigen (HBsAg) or anti-hepatitis B core antibody (anti-HBc). · Presence of hepatitis C virus (HCV) ...

  4. B. Mark Keegan, M.D. - Doctors and Medical Staff - Mayo Clinic

    He then completed two years subspecialty fellowship in Neuroimmunology and Multiple Sclerosis at Mayo Clinic in Rochester Minnesota. He joined the faculty of ...

  5. ATHN 11: A Study of Liver Transplantation Outcomes - Mayo Clinic

    The purpose of this study is to observe participants with hemophilia A and B who have and have not undergone liver transplantation. ... Hepatitis C virus (HCV) ...

  6. Erectile dysfunction - Doctors and departments - Mayo Clinic

    Internist. Phoenix, AZ. Areas of focus: LGBT health care, Erectile dysfunction, Sexual dysfunction, Hepatitis C, Hepatitis B, Sexually transmitted disease, HIV.

  7. Publications - Doug A. Simonetto, M.D. - Mayo Clinic

    ... B, Marciano S, Sarin SK, Durand F, Gines P ... Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone.

  8. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

    ... B-cell Hematologic Malignancies. Print details. Share; Facebook ... Patients with active hepatitis B or hepatitis C infections are excluded from the study.

  9. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

    ... hepatitis B (HBV), or hepatitis C virus (HCV): a. Patients with HIV are excluded. a.b. Patients who are hepatitis B surface antigen positive are eligible if ...

  10. Transmission Of Hepatitis C Infection To Patients - Mayo Clinic News Network

    An extensive investigation into hepatitis C infections in three transplant patients led investigators to uncover the route of transmission.